Pathology correlates of a papanicolaou diagnosis of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion

Cancer Cytopathology

Volumn 114, Issue 6, 2008, Pages 469-473

  Al Nourhji, Omar ^a   Beckmann, Michael J ^b   Markwell, Stephen J ^a   Massad, L Stewart ^c  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannot exclude highgrade squamous intraepithelial lesion; Cervical intraepithelial neoplasia; Low grade squamous intraepithelial lesion; Papanicolaou test

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 59849118696     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncr.23984     Document Type: Review

References (18)

1. Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology Definitions, Criteria and Explanatory Notes. New York, NY: Springer-Verlag; 2004.
2. Sherman ME, Solomon D, Schiffman M;ASCUS LSIL Triage Study Group. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol. 2001;116:386-394.
3. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkerson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287: 2120-2129.
4. Wright TC Jr, Cox JT, Massad LS, et al. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007; 197:346-355.
5. Richart RM. Cervical intraepithelial neoplasia: a review. In: Sommers SC, ed. Pathology Annual. East Norwalk, Conn: Appleton-Century-Crafts; 1973:301-328.
6. Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol. 2007;197:356.e1-e6.
7. Elsheikh TM, Kirkpatrick JL, Wu HH. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests. Cancer (Cancer Cytopathol). 2006;108:277-281.
8. Shidham VB, Kumar N, Narayan R, Brotzman GL. Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature [serial online]. Cytojournal. 2007;4:7.
9. Booth CNM-WR, Salhadar A, Weirick J, Wojcik EM. Is LSIL, cannot exclude HSIL (LGHSIL) a valid Pap test interpretation [abstract]? Mod Pathol. 2005;18:61A
10. Nasser SM, Cibas ES, Crum CP, Faquin WC. The significance of the Papanicolaou smear diagnosis of low-grade squamous intraepithelial lesion cannot exclude high-grade squamous intraepithelial lesion. Cancer (Cancer Cytopathol). 2003;99:272-276.
11. Owens CL, Moats DR, Burroughs FH, Gustafson KS. "Lowgrade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" is a distinct cytologic category: histologic outcomes and HPV prevalence. Am J Clin Pathol. 2007;128:398-403.
12. Kir G, Cetiner H, Gurbuz A, Karateke A. Reporting of LSIL with ASC-H on cervicovaginal smears: is it a valid category to predict cases with HSIL follow-up? Eur J Gynaecol Oncol. 2004;25:462-464.
13. Power P, Gregoire J, Duggan M, Nation J. Low-grade Pap smears containing occasional high-grade cells as a predictor of high-grade dysplasia. J Obstet Gynaecol Cancer. 2006;28:884-887.
14. Underwood D, Prok A, Booth C, Brainard J, Chen L. Clinical outcomes of patients with a cytologic interpretation of "LSIL cannot exclude HSIL (LSIL-H)" in Pap test: a retrospective follow-up study [abstract]. Cancer (Cancer Cytopathol). 2006;108:378.
15. DiFurio M, Mailhiot T, Nauscheutz K. Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H [abstract]. Cancer (Cancer Cytopathol). 2005;105:351.
16. McGrath CM, Kurtis JD, Yu GH. Evaluation of mild-tomoderate dysplasia on cervical-endocervical (Pap) smear: a subgroup of patients who bridge LSIL and HSIL. Diagn Cytopathol. 2000;23:245-248.
17. O'Brien D, Brainard J, Chen L, Prok A, Booth C. Impact of the ThinPrep imaging system on the frequency of LSIL, cannot exclude HSIL: correlation of HPV and followup data [abstract]. Cancer (Cancer Cytopathol). 2006;108: 383.
18. The ALTS Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;183:1383-1392.